Cyclodextrins and their uses: A review

Process Biochemistry

Volumn 39, Issue 9, 2004, Pages 1033-1046

  Del Valle, E M Martin ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Applications; Complexation techniques; Cyclodextrins; Equilibrium; Inclusion complex

Indexed keywords

EID: 1942470488     PISSN: 00329592     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0032-9592(03)00258-9     Document Type: Review

References (83)

1. Villiers A. Compt Rendu. 112:1891;536
2. Eastburn S.D., Tao B.Y. Applications of modified cyclodextrins. Biotechnol. Adv. 12:1994;325-339
3. Szetjli J. Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98:1998;1743-1753
4. Stella V.J., Rajewski R.A. Cyclodextrins: their future in drug formulation and delivery. Pharm. Res. 14:1997;556-5567
5. Matsuda H., Arima H. Cyclodextrins in transdermal and rectal delivery. Adv. Drug Deliv. Rev. 36:1999;81-99
6. Mabuchi N, Ngoa M. Controlled release powdered flavour preparations and confectioneries containing preparations. Japanese Patent JP 128, 638 (2001).
7. Buschmann HJ, Schollmeyer E. Applications of cyclodextrins in cosmetic products: a review. J Cosmet Sci 2002;53:575-92.
8. Hirose T, Yamamoto Y. Hinokitol containing cyclo-olefin polymer compositions and their molding with excellent antimicrobial and gas barrier properties. Japanese Patent JP 55480 (2001).
9. Hedges R.A. Industrial applications of cyclodextrins. Chem. Rev. 98:1998;2035-2044
10. Lu X., Chen Y. Chiral separation of amino acids derivatized with fluoresceine-5-isothiocyanate by capillary electrophoresis and laser-induced fluorescence detection using mixed selectors of beta-cyclodextrin and sodium taurocholate. J. Chromatogr. A. 955:2002;133-140
11. Baudin C., Pean C., Perly B., Goselin P. Inclusion of organic pollutants in cyclodextrin and derivatives. Int. J. Environ. Anal. Chem. 77:2000;233-242
12. Kumar R., Dahiya J.S., Singh D., Nigam P. Biotransformation of cholesterol using Lactobacillus bulgaricus in glucose controlledbioreactor. Bioresour Technol. 28:2001;209-211
13. Koukiekolo R., Desseaux V., Moreau Y., Marchis M.G., Santimone M. Mechanism of porcine pancreatic alpha-amylase inhibition of amylose and maltopentaose hydrolysis by alpha-, beta- and gamma-cyclodextrins. Eur. J. Biochem. 268:2001;841-848
14. Szetjli J. Downstream processing using cyclodextrins. TIBTRCH. 7:1989;171-174
15. Dass C.R., Jessup W., Apolipoprotiens A.-I. Cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis. J. Pharm. Pharmacol. 52:2000;731-761
16. Nash RA. Cyclodextrins. In: Wade A, Weller PJ, editors. Handbook of pharmaceutical excipients. London: Pharm. Press & Am. Pharm. Assoc.; 1994. p. 145-8.
17. Irie T., Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 86:1997;147-162
18. Thompson D.O. Cyclodextrins-enabling excipients: their present and future use in pharmaceuticals. Crit. Rev. Ther. Drug Carrier Syst. 14:1997;1-104
19. Totterman A.M., Schipper N.G., Thompson D.O., Mannermaa J.P. Intestinal safety of water-soluble β-cyclodextrins in paediatric oral solutions of spironolactone: effects on human intestinal epithelial Caco-2 cells. J. Pharm. Pharmacol. 49:1997;43-48
20. Szente L., Szejtli J., Kis G.L. Spontaneous opalescence of aqueous γ-cyclodextrin solutions: complex formation or self-aggregation. J. Pharm. Sci. 87:1998;778-781
21. Muñoz-Botella S., del Castillo B., Martyn M.A. Cyclodetrin properties and applications of inclusion complex formation. Ars. Pharm. 36:1995;187-198
22. Loftsson T., Brewster M.E. Pharmaceutical applications of cyclodextrins: 1. Drug solubilisation and stabilization. J. Pharm. Sci. 85:1996;1017-1025
23. Schneiderman E., Stalcup A.M. Cyclodextrins: a versatile tool in separation science. J. Chromatogr. B. 745:2000;83-102
24. Schmid G. Cyclodextrin glucanotransferse production: yield enhancement by overexpression of cloned genes. Trends Biotechnol. 7:1989;244-248
25. Fujishima N, Kusaka K, Umino T, Urushinata T, Terumi K. Flour based foods containing highly branched cyclodextrins. Japanese Patent JP 136, 898 (2001).
26. Bhardwaj R., Dorr R.T., Blanchard J. Approaches to reducing toxicity of parenteral anticancer drug formulations using cyclo-dextrins. J. Pharm. Sci. Technol. 54:2000;233-239
27. Holland L, Rizzi G, Malton P. Cosmetic compositions comprising cyclic oligosaccharides and fragrance. PCT Int Appl WO 67, 716 (1999).
28. Lezcano M., Ai-Soufi W., Novo M., Rodriguez-Nunez E., Tato J.V. Complexation of several benzimidazole-type fungicides with alpha and beta-cyclodextrins. J. Agric. Food Chem. 50:2002;108-112
29. Dufosse L., Souchon I., Feron G., Latrasse A., Spinnler H.E. In situ detoxification of the fermentation medium during gamma-decalactone production with the yeast Sporidiobolus salmonicolor. Biotechnol. Prog. 15:1999;135-139
30. Hedges R.A. Industrial applications of cyclodextrins. Chem. Rev. 98:1998;2035-2044
31. Frömming KH, Szejtli J. Cyclodextrins in pharmacy. Topics in inclusion science. Dordrecht: Kluwer Academic Publishers; 1994.
32. Hirayama F, Uekama K. Methods of investigating and preparing inclusion compounds. In: Duchêne D, editor. Cyclodextrins and their industrial uses. Paris: Editions de Santé; 1987. p. 131-72.
33. Higuchi T., Connors K.A. Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4:1965;117-212
34. Sigurdardottir A.M., Loftsson T. The effect of polyvinylpyrrolidone on cyclodextrin complexation of hydrocortisone and its diffusion through hairless mouse skin. Int. J. Pharm. 126:1995;73-78
35. Hussain M.A., Diluccio R.C., Maurin M.B. Complexation of moricizine with nicotinamide and evaluation of the complexation constants by various methods. J. Pharm. Sci. 82:1993;77-79
36. Loftsson T. Effects of cyclodextrins on chemical stability of drugs in aqueous solutions. Drug Stabil. 1:1995;22-33
37. Másson M., Loftsson T., Jónsdóttir S., Fridriksdóttir H., Petersen D.S. Stabilisation of drugs through complexation with non-ionic and ionic cyclodextrins. Int. J. Pharm. 164:1998;45-55
38. Liu F., Kildsig D.O., Mitra A.K. Cyclodextrin/weak-electrolyte complexation: interpretation and estimation of association constants from phase solubility diagrams. Pharm. Res. 9:1992;1671-1672
39. Suzuki M., Ito K., Fushimi C., Kondo T. The freezing point depression method for the determination of binding parameters of drugs by polyvinylpyrrolidone and polyoxyethylene n-dodecylether. Chem. Pharm. Bull. 41:1993;1616-1620
40. Connors K.A. The stability of cyclodextrin complexes in solution. Chem. Rev. 97:1997;1325-1357
41. Connors K.A. Population characteristics of cyclodextrin complex stabilities in aqueous solution. J. Pharm. Sci. 84:1995;843-848
42. Higuchi T., Connors K.A. Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4:1965;117-212
43. Martin A. Physical pharmacy, 4th ed. Philadelphia: Lea & Fedbiger; 1993.
44. Bergeron RJ. Cycloamylose-substrate binding. Inclision Compounds. London: Academic Press; 1984.
45. Loftsson T., Brewster M.E. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85:1996;1017-1025
46. Loftsson T., Ólafsdóttir B.J., Fridriksdóttir H., Jónsdóttir S. Cyclodextrin complexation of NSAIDS: physicochemical characteristics. Eur. J. Pharm. Sci. 1:1993;95-101
47. Pitha J., Hoshino T. Effects of ethanol on formation of inclusion complexes of hydroxypropylcyclodextrins with testosterone or with methyl organe. Int. J. Pharm. 80:1992;243-251
48. Loftsson T., Stefansdottir Ó., Fridriksdottir H., Gudmundsson Ö. Interaction between preservatives and 2-hydroxypropyl-b-cyclodextrin. Drug Devel. Ind. Pharm. 18(13):1992;1477-1484
49. Furuta T., Yoshii H., Miyamoto A., Yasunishi A., Hirano H. Effects of water of inclusion complexes of d-limonene and cyclodextrins. Supramol. Chem. 1:1993;321-325
50. Torres-Labandeira J.J., Davignon P., Pitha J. Oversaturated solutions of drug in hydroxypropylcyclodextrins: parenteral preparation of pancratistatin. J. Pharm. Sci. 80:1990;384-386
51. Singh M, Sharma R, Banerjee UC. Biotechnological applications of cyclodextrins. Biotechnol Adv 2002;20:341-59.
52. Prasad N, Strauss D, Reichart G. Cyclodextrins inclusion for food, cosmetics and pharmaceuticals. European Patent 1, 084, 625 (1999).
53. Tatsuya S. Stabilisation of fragrance in bathing preparations. Japanese Patent 11, 209, 787 (1999).
54. Trinh J, Dodd TM, Bartolo R, Lucas JM. Cyclodextrin based compositions for reducing body odour. US Patent 5, 897, 855 (1999).
55. Woo RAM, Trinh T, Cobb DS, Schneiderman E, Wolff, AM, Rosenbalm EL, Ward TE, Chung AH, Reece S. Uncomplexed cyclodextrin compositions for odour control. US Patent 5, 942, 217 (1999).
56. Foley PR, Kaiser CE, Sadler JD, Burckhardt EE, Liu Z. Detergent composition with cyclodextrin perfume complexes to mask malodours. PCT Int Appl WO 01 23, 516 (2000).
57. Angell WF, France, PA. Detergent composition having granular cyclodextrin. PCT Int Appl WO 01 18, 163 (2001).
58. Loftsson T., Leeves N., Bjornsdottir B., Duffy L., Masson M. Effect of cyclodextrins and polymers on triclosan availability and substantivity in toothpastes in vivo. J. Pharm. Sci. 88:1999;1254-1258
59. Scalia S., Villani S., Casolari A. Inclusion complexation of the sunscreen agent 2-ethylhexyl-p-dimethylaminobenzoate with hydroxypropyl-beta- cyclodextrin: effect on photostability. J. Pharm. Pharmacol. 51:1999;1367-1374
60. Parrish MA. Cyclodextrins - a review. England: Sterling Organics; 1988 (Newcastle-upon-Tyne NE3 3TT).
61. Sojo M.M., Nunez-Delicado E., Garcia-Carmona F., Sanchez-Ferrer A. Cyclodextrins as activator and inhibitor of latent banana pulp polyphenol oxidase. J. Agric. Food Chem. 47:1999;518-523
62. Sung H. Composition for ginger preservation. Republic of Korea KR 9, 707, 148 (1997).
63. Sumiyoshi H. Utilisation of inclusion complexes with plant components for foods. Nippon Shokuhin Shinsozai Kenkyukaishi. 2:1999;109-114
64. Takeshita K, Urata T. Antimicrobial food preservatives containing cyclodextrin inclusion complexes. Japanese Patent JP 29, 054 (2001).
65. Frömming KH, Szejtli J. Cyclodextrins in pharmacy. Topics in inclusion science. Dordrecht: Kluwer Academic Publishers; 1994.
66. Rajewski R.A., Stella V.J. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J. Pharm. Sci. 85:1996;1142-1168
67. Uekama K., Adachi H., Irie T., Yano T., Saita M. Improved transdermal delivery of prostaglandin E 1 through hairless mouse skin: combined use of carboxymethyl-ethyl-b-cyclodextrin and penetration enhancers. J. Pharm. Pharmacol. 44:1992;119-121
68. Kristmundsdóttir T., Loftsson T., Holbrook W.P. Formulation and clinical evaluation of a hydrocortisone solution for treatment of oral disease. Int. J. Pharm. 139:1996;63-68
69. Kublik H., Bock T.K., Schreier H., Müller B.W. Nasal absorption of 17b-estradiol from different cyclodextrin inclusion formulations in sheep. Eur. J. Pharm. Biopharm. 42:1996;320-324
70. Loftsson T., Stefánsson E. Effect of cyclodextrins on topical drug delivery to the eye. Drug Devel. Ind. Pharm. 23:1997;473-481
71. van Dorne H. Interaction between cyclodextrins and ophthalmic drugs. Eur. J. Pharm. Biopharm. 39:1993;133-139
72. Jarho P., Urtti A., Pate D.W., Suhonen P., Järvinen T. Increase in aqueous solubility. Int. J. Pharm. 137:1996;209-217
73. Irie T., Uekama K. Cyclodextrins in peptide and protein delivery. Adv. Drug Deliv. Rev. 36:1999;101-123
74. Zhao T., Temsamani J., Agarwal S. Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery. Antisense Res. 5:1995;185-192
75. Ekberg B., Anderson L., Mosbach K. The synthesis of an active derivative of cyclomalto hexose for the hydrolysis of esters and the formation of amide bonds. Carbohydr. Res. 192:1989;111-117
76. Morozumi T., Uetsuka H., Komiyama M., Pitha J. Selective synthesis using cyclodextrins as catalyst. 6. Cyclodextrin modification for para-selective hydroxymethylation and hydroxyetheylation of phenol. J. Mol. Catal. 70:1991;399-406
77. Atwood JL. Inclusion phenomenon and molecular recognition. New York: Plenum; 1990.
78. Kamal A., Rabalingum T., Venugopalan N. Enantioselective hydrolysis of aryloxypopionic esters by bovine serum albumin: enhancement in selectivity by β-CD. Tetrahedron: Asymmetry. 2:1991;39
79. Rao K.R., Bhanumathi N., Srinivasan T.N., Sattur P.B. A regioselective enzyme catalysed cycloaddition. Tetrahedron Letters. 31:1990;892-899
80. Gao S., Wang L. Application of cyclodextrin in environmental science. Huanjing Kexue Jinzhan. 6:1998;80-86
81. Wu C., Fan J. Applications of cyclodextrin to water treatment. Shuichuli Jishu. 24:1998;67-70
82. Reid BJ, Semple KT, Jhones KC. Soil test for determining bioavailability of pollutants. PCT Int Appl WO 99 54, 727 (1999).
83. Bardi L., Mattei A., Steffan S., Marzona M. Hydrocarbon degradation by a soil microbial population with beta-cyclodextrin as surfactant to enhance bioavailability. Enzyme Microb. Technol. 27:2000;709-713